Online citations, reference lists, and bibliographies.

Proceedings Of The 3rd Annual Albert Institute For Bladder Cancer Research Symposium

Thomas Flaig, Ashish M. Kamat, Donna E Hansel, Molly A. Ingersoll, H. Barton Grossman, Cathy L Mendelsohn, David J Degraff, Joseph C Liao, John A.M. Taylor
Published 2017 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
The Third Annual Albert Institute Bladder Symposium was held on September 8–10th, 2016, in Denver Colorado. Participants discussed several critical topics in the field of bladder cancer: 1) Best practices for tissue analysis and use to optimize correlative studies, 2) Modeling bladder cancer to facilitate understanding and innovation, 3) Targeted therapies for bladder cancer, 4) Tumor phylogeny in bladder cancer, 5) New Innovations in bladder cancer diagnostics. Our understanding of and approach to treating urothelial carcinoma is undergoing rapid advancement. Preclinical models of bladder cancer have been leveraged to increase our basic and mechanistic understanding of the disease. With the approval of immune checkpoint inhibitors for the treatment of advanced urothelial carcinoma, the treatment approach for these patients has quickly changed. In this light, molecularly-defined subtypes of bladder cancer and appropriate pre-clinical models are now essential to the further advancement and appropriate application of these therapeutic improvements. The optimal collection and processing of clinical urothelial carcinoma tissues samples will also be critical in the development of predictive biomarkers for therapeutic selection. Technological advances in other areas including optimal imaging technologies and micro/nanotechnologies are being applied to bladder cancer, especially in the localized setting, and hold the potential for translational impact in the treatment of bladder cancer patients. Taken together, advances in several basic science and clinical areas are now converging in bladder cancer. These developments hold the promise of shaping and improving the clinical care of those with the disease.
This paper references
Characterization of human uroepithelial cells immortalized in vitro by simian virus 40.
B J Christian (1987)
10.1038/nrc1697
Urothelial tumorigenesis: a tale of divergent pathways
Xue-Ru Wu (2005)
10.1016/j.eururo.2016.02.029
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.
Holger Moch (2016)
10.1007/978-1-4939-1164-6_10
3D culture assays of murine mammary branching morphogenesis and epithelial invasion.
Kim-Vy Nguyen-Ngoc (2015)
10.1007/s10544-015-0029-8
A parallelized microfluidic DNA bisulfite conversion module for streamlined methylation analysis
Alejandro Stark (2016)
10.1038/sj.onc.1209513
Expression of hTERT immortalises normal human urothelial cells without inactivation of the p16/Rb pathway
Emma J Chapman (2006)
10.1101/gad.1772909
Inactivation of p53 and Pten promotes invasive bladder cancer.
Anna M. Puzio-Kuter (2009)
10.1093/hmg/dds486
Oncogenic FGFR3 gene fusions in bladder cancer
Sarah V. Williams (2013)
10.1016/j.urolonc.2011.07.017
When urothelial differentiation pathways go wrong: implications for bladder cancer development and progression.
David J Degraff (2013)
10.1038/nrm3873
Three-dimensional organotypic culture: experimental models of mammalian biology and disease
Eliah R. Shamir (2014)
10.1016/J.JURO.2016.03.130
PI-LBA07 THE DEVELOPMENT AND CLINICAL VALIDATION OF A HIGH SENSITIVITY URINE BIOMARKER TEST FOR THE DETERMINATION OF RECURRENCE IN UROTHELIAL CARCINOMA PATIENTS
Yair Lotan (2016)
10.1016/j.cell.2014.08.016
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Dong Gao (2014)
10.18632/oncotarget.8114
Role of isoenzyme M2 of pyruvate kinase in urothelial tumorigenesis
Haiping Zhou (2016)
10.1038/NATURE12965
Comprehensive molecular characterization of urothelial bladder carcinoma
John N. Weinstein (2014)
10.1158/0008-5472.CAN-15-1313
Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models.
Pia M. Challita-Eid (2016)
Organoid culture systems for prostate epithelial and cancer tissue
J Drost (2016)
10.1038/ncb2956
Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma
Kunyoo Shin (2014)
Inactivation of p 53 and Pten promotes invasive bladder cancer
Anna M. Puzio-Kuter (2009)
10.1016/j.juro.2012.03.127
New optical imaging technologies for bladder cancer: considerations and perspectives.
Jen‐Jane Liu (2012)
10.3389/fgene.2012.00268
Gender Differences in Cancer Susceptibility: An Inadequately Addressed Issue
Mehmet Tevfik Dorak (2012)
10.18632/ONCOSCIENCE.188
Tumorigenicity of RTK/RAS in urothelium
Xue-Ru Wu (2015)
10.1083/jcb.201306088
Twist1-induced dissemination preserves epithelial identity and requires E-cadherin
Eliah R. Shamir (2014)
10.1039/c0lc00296h
A surface topography assisted droplet manipulation platform for biomarker detection and pathogen identification.
Yi Zhang (2011)
10.1152/ajprenal.00327.2009
Cell biology and physiology of the uroepithelium.
Puneet Khandelwal (2009)
10.1006/cbir.2000.0658
Restoration of the rat urothelium after cyclophosphamide treatment.
Rok Romih (2001)
10.1038/nmat1508
Single-quantum-dot-based DNA nanosensor
Chun-Yang Zhang (2005)
10.1002/cncr.22756
Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients.
Ashish M. Kamat (2007)
10.1016/j.ccell.2016.06.012
Molecular Subtypes of Non-muscle Invasive Bladder Cancer.
Seth P. Lerner (2016)
10.1126/scitranslmed.3003586
Preexisting BCG-Specific T Cells Improve Intravesical Immunotherapy for Bladder Cancer
Claire Biot (2012)
10.1364/BOE.8.002106
3D reconstruction of cystoscopy videos for comprehensive bladder records.
Kristen L. Lurie (2017)
Molecular Subtypes of Nonmuscle Invasive Bladder Cancer
SP Lerner (2016)
10.1038/nrurol.2014.130
Landmarks in non-muscle-invasive bladder cancer
Laura S. Mertens (2014)
10.1242/dmm.006874
K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder
Imran Ahmad (2011)
10.1002/adma.201300383
Full-range magnetic manipulation of droplets via surface energy traps enables complex bioassays.
Yiren Zhang (2013)
10.1007/978-3-319-20669-1_18
Harnessing the Host Immune Response to Infection – BCG Immunotherapy for Bladder Cancer
Hana Zdimerova (2015)
10.1053/j.seminoncol.2016.01.002
The Bayesian basket design for genomic variant-driven phase II trials.
Richard M. Simon (2016)
10.1038/nrc.2016.124
The recurrent architecture of tumour initiation, progression and drug sensitivity
Andrea Califano (2017)
Center experience with 100 consecutive patients
CB Ching (2007)
10.1158/1078-0432.CCR-12-0077-T
A Molecular Taxonomy for Urothelial Carcinoma
Gottfrid Sjödahl (2012)
10.1073/pnas.0900343106
Endogenous expression of HrasG12V induces developmental defects and neoplasms with copy number imbalances of the oncogene
Xiang Chen (2009)
10.1111/j.1464-410X.2009.08577.x
Mouse orthotopic models for bladder cancer research.
Eddie Y. Y. Chan (2009)
Anderson Cancer Center experience with 100 consecutive patients
(2007)
10.1097/MOT.0000000000000084
Formation and regeneration of the urothelium
Tammer Yamany (2014)
Char - acterization of human uroepithelial cells immortalized in vitro by simian virus 40
BJ Christian (1987)
10.1038/ncomms11914
KRT14 marks a subpopulation of bladder basal cells with pivotal role in regeneration and tumorigenesis
George Papafotiou (2016)
10.1073/pnas.1313580111
Whole-genome sequencing identifies genomic heterogeneity at a nucleotide and chromosomal level in bladder cancer
Carl D. Morrison (2014)
10.1007/s11934-014-0406-5
Emerging Endoscopic Imaging Technologies for Bladder Cancer Detection
Aristeo Cuauhtemoc Deloya Lopez (2014)
10.1126/scitranslmed.3009457
Endoscopic molecular imaging of human bladder cancer using a CD47 antibody
Ying Pan (2014)
10.1007/s00280-015-2868-7
Pharmacodynamics (PD) and pharmacokinetics (PK) of E7389 (eribulin, halichondrin B analog) during a phase I trial in patients with advanced solid tumors: a California Cancer Consortium trial
Robert J. Morgan (2015)
10.1242/dev.117903
An illustrated anatomical ontology of the developing mouse lower urogenital tract
Kylie M Georgas (2015)
10.1007/s10555-009-9189-4
Biology of urothelial tumorigenesis: insights from genetically engineered mice
Xue-Ru Wu (2009)
10.1001/jama.2011.1142
Association between smoking and risk of bladder cancer among men and women.
Neal D Freedman (2011)
10.1038/ki.2009.73
Uroplakins in urothelial biology, function, and disease.
Xue-Ru Wu (2009)
Abate-Shen C. Modelling bladder cancer in mice: Opportunities and challenges
T Kobayashi (2015)
10.1016/j.cell.2013.11.029
Collective Invasion in Breast Cancer Requires a Conserved Basal Epithelial Program
Kevin J. Cheung (2013)
10.1186/s12864-015-1450-3
The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies
Julie Earl (2015)
10.1016/j.ccell.2016.05.004
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma.
Jakob Hedegaard (2016)
10.1038/nrc3858
Modelling bladder cancer in mice: opportunities and challenges
Takashi Kobayashi (2014)
10.1007/s40273-014-0194-2
The Health Economics of Bladder Cancer: An Updated Review of the Published Literature
Christina Yeung (2014)
10.1016/j.ccr.2014.01.026
Molecular subtyping of invasive bladder cancer: time to divide and rule?
Carolyn D. Hurst (2014)
10.1016/0006-2952(79)90222-3
Cyclophosphamide cystitis--identification of acrolein as the causative agent.
Philip J. Cox (1979)
plakins in urothelial biology , function , and disease
XR Wu (2009)
10.1016/j.urolonc.2009.11.004
Considerations on implementing diagnostic markers into clinical decision making in bladder cancer.
Yair Lotan (2010)
10.1007/s10654-011-9647-5
Enigmatic sex disparities in cancer incidence
Gustaf Edgren (2011)
10.1073/pnas.1508541113
Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters
Kevin J. Cheung (2016)
10.1158/0008-5472.CAN-09-2158
Deficiency of pRb family proteins and p53 in invasive urothelial tumorigenesis.
Feng He (2009)
Novel endoscopic diagnosis for bladder
SP Lerner (2015)
10.1002/cncr.28905
Novel endoscopic diagnosis for bladder cancer.
Seth P. Lerner (2015)
10.1038/nature12965
Comprehensive Molecular Characterization of Urothelial Bladder Carcinoma
The Cancer Genome Atlas Research Network (2014)
The
H Moch (2016)
10.1038/nature12912
Discovery and saturation analysis of cancer genes across 21 tumor types
Michael S. Lawrence (2014)
10.1038/416187a
The endophilin–CIN85–Cbl complex mediates ligand-dependent downregulation of c-Met
Annalisa Petrelli (2002)
Char - acterization of human uroepithelial cells immortalized in vitro by simian virus 40
EJ Chapman (1987)
10.1038/SJ.KI.5002589
Down the tube of obstructive nephropathies: the importance of tissue interactions during ureter development.
Rannar Airik (2007)
10.1038/sj.onc.1207169
p53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesis
Jing Gao (2004)
Discovery and saturation analysis of cancer genes across 21 tumour
MS Lawrence (2014)
10.1038/nrurol.2014.129
Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer
Woonyoung Choi (2014)
10.1364/OL.40.003165
Rapid scanning catheterscope for expanded forward-view volumetric imaging with optical coherence tomography.
Kristen L. Lurie (2015)
10.1016/S0140-6736(16)00561-4
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E Rosenberg (2016)
10.1038/nature09851
Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder
Kunyoo Shin (2011)
10.1016/j.juro.2016.10.101
INTRACAVITARY BACILLUS CALMETTE‐GUERIN IN THE TREATMENT OF SUPERFICIAL BLADDER TUMORS
Alvaro Morales (2017)
10.1371/journal.pone.0038863
Integrated Genomic and Gene Expression Profiling Identifies Two Major Genomic Circuits in Urothelial Carcinoma
David Lindgren (2012)
10.1038/modpathol.2011.69
HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization
Christina B. Ching (2011)
10.1126/science.aaf6546
A collective route to metastasis: Seeding by tumor cell clusters
Kevin J. Cheung (2016)
10.1038/416183a
Cbl–CIN85–endophilin complex mediates ligand-induced downregulation of EGF receptors
Philippe Soubeyran (2002)
10.1038/ncb3038
Bladder cancers arise from distinct urothelial sub-populations
Jason P. Van Batavia (2014)
10.1038/nm.2554
Cancer Cell-Selective In Vivo Near Infrared Photoimmunotherapy Targeting Specific Membrane Molecules
Makoto Mitsunaga (2011)
10.1038/ng.3503
Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer
Hikmat A. Al-Ahmadie (2016)
10.1117/1.JBO.19.3.036009
Three-dimensional, distendable bladder phantom for optical coherence tomography and white light cystoscopy
Kristen L. Lurie (2014)
10.1016/j.devcel.2013.07.017
Retinoid signaling in progenitors controls specification and regeneration of the urothelium.
Devangini Gandhi (2013)
10.1126/scitranslmed.3008970
EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype
Sandra Rebouissou (2014)
10.1016/S0022-5347(17)39721-5
Comparison of antigen expression on normal urothelial cells in tissue section and tissue culture.
Monica Liebert (1990)
10.1364/BOE.7.004995
Registration of free-hand OCT daughter endoscopy to 3D organ reconstruction.
Kristen L. Lurie (2016)
10.1364/BOE.7.000648
Multimodal 3D cancer-mimicking optical phantom.
Gennifer T. Smith (2016)
10.1111/j.1464-410X.2007.06773.x
Acute acrolein-induced cystitis in mice.
Dale E. Bjorling (2007)
10.1093/jnci/djp361
A case-control study of smoking and bladder cancer risk: emergent patterns over time.
Dalsu Baris (2009)
10.1016/j.juro.2012.11.084
Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis.
Farshid Dayyani (2013)
10.4161/cbt.25326
A Smac mimetic augments the response of urothelial cancer cells to gemcitabine and cisplatin
Eugene K Lee (2013)
10.1016/j.ccr.2014.01.009
Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.
Woonyoung Choi (2014)
10.1016/j.cell.2014.06.049
Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin
Katherine A. Hoadley (2014)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar